{"podcast":{"title":"Hematologic Oncology Update","slug":"hematologic-oncology-update-916423","podcast_index_feed_id":916423,"rss_url":"https://feeds.captivate.fm/hematologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/hematologic-oncology","image_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png","author":"Dr. Neil Love","episode_count":161,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.","last_synced_at":"2026-09-26T04:24:25.521627+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423"},"episode":{"title":"Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1","slug":"chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1","published_at":"2026-07-27T16:30:00+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1","show_page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423","url":"https://hematologic-oncology.captivate.fm/episode/5959-cllmicro2025-5mjc-1","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/bd9350d0-6b13-4d77-a236-0287422a9f82.mp3","summary":"Featuring perspectives from Dr Mazyar Shadman, including the following topics: The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00) The AMPLIFY trial: Fixed-duration acalabrutinib combinations for untreated CLL (5:31) Zanubrutinib-based therapy for treatment-naïve CLL (12:32) CME information and select publications","meta_description":"Featuring perspectives from Dr Mazyar Shadman, including the following topics: The CLL17 trial: Fixed-duration versus continuous targeted treatment for pr…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1337,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-1.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}